“Wim is a very intelligent person with a bright mind - able to bridge topics that were initially not clearly related. He can deal with multiple problems at the same time while remaining calm and charming as ever. I've learned a lot from him, including thinking out of the box and stay optimistic in all conditions.”
Activity
-
Been waiting to post this one for a loooong time 🎪 It’s official, Wintercircus Ghent is opening its doors! Stop by during our opening weekend…
Been waiting to post this one for a loooong time 🎪 It’s official, Wintercircus Ghent is opening its doors! Stop by during our opening weekend…
Liked by Wim Van Criekinge
-
Stories, experiences & learning in 🇺🇸 - part 4! Many people say that the Bay Area has a unique type of energy to it, an energy of going for it…
Stories, experiences & learning in 🇺🇸 - part 4! Many people say that the Bay Area has a unique type of energy to it, an energy of going for it…
Liked by Wim Van Criekinge
-
At OHMX.bio, we are dedicated to delivering the most scientifically sound solutions. With strong ties to academia, we stay at the forefront of…
At OHMX.bio, we are dedicated to delivering the most scientifically sound solutions. With strong ties to academia, we stay at the forefront of…
Liked by Wim Van Criekinge
Patents
-
Markers for Improved Detection of Breast Cancer
Issued US WO2009108917
Several genes are identified as being differentially methylated in breast cancers. This information is useful for breast cancer screening, risk-assessment, prognosis, disease identification, disease staging, and identification of therapeutic targets. The identification of genes that are methylated in breast cancer allows accurate and effective early diagnostic assays, methylation profiling using multiple genes and identification of new targets for therapeutic intervention.
Other inventorsSee patent -
Detection and prognosis of lung cancer
Issued US WO2009105549
Methods and tools are provided for detecting and predicting lung cancer. The methods and tools are based on epigenetic modification due to methylation of genes in lung cancer or pre-lung cancer. The tools can be assembled into kits or can be used seperately. Genes found to be epigentically silenced in association with lung cancer include ACSL6, ALS2CL, APC2, ARTS1, BEX1, BMP7, BNIP3, CBR3, CD248, CD44, CHD5, DLK1, DPYSL4, DSC2, EDNRB, EPB41L3, EPHB6, ERBB3, FBLN2, FBN2, FOXL2, GNAS, GSTP1…
Methods and tools are provided for detecting and predicting lung cancer. The methods and tools are based on epigenetic modification due to methylation of genes in lung cancer or pre-lung cancer. The tools can be assembled into kits or can be used seperately. Genes found to be epigentically silenced in association with lung cancer include ACSL6, ALS2CL, APC2, ARTS1, BEX1, BMP7, BNIP3, CBR3, CD248, CD44, CHD5, DLK1, DPYSL4, DSC2, EDNRB, EPB41L3, EPHB6, ERBB3, FBLN2, FBN2, FOXL2, GNAS, GSTP1, HS3ST2, HPN, IGFBP7, IRF7, JAM3, LOX, LY6D, LY6K, MACF1, MCAM, NCBP1, NEFH, NID2, PCDHB15, PCDHGA12, PFKP, PGRMC1, PHACTR3, PHKA2, POMC, PRKCA, PSEN1, RASSF1A, RASSF2, RBP1, RRAD, SFRP1, SGK, SOD3, SOX17, SULF2, TIMP3, TJP2, TRPV2, UCHL1, WDR69, ZFP42, ZNF442, and ZNF655.
Other inventorsSee patent -
Detection and prognosis of lung cancer
Issued US WO2009105549
Methods and tools are provided for detecting and predicting lung cancer. The methods and tools are based on epigenetic modification due to methylation of genes in lung cancer or pre-lung cancer. The tools can be assembled into kits or can be used seperately. Genes found to be epigentically silenced in association with lung cancer include ACSL6, ALS2CL, APC2, ARTS1, BEX1, BMP7, BNIP3, CBR3, CD248, CD44, CHD5, DLK1, DPYSL4, DSC2, EDNRB, EPB41L3, EPHB6, ERBB3, FBLN2, FBN2, FOXL2, GNAS, GSTP1…
Methods and tools are provided for detecting and predicting lung cancer. The methods and tools are based on epigenetic modification due to methylation of genes in lung cancer or pre-lung cancer. The tools can be assembled into kits or can be used seperately. Genes found to be epigentically silenced in association with lung cancer include ACSL6, ALS2CL, APC2, ARTS1, BEX1, BMP7, BNIP3, CBR3, CD248, CD44, CHD5, DLK1, DPYSL4, DSC2, EDNRB, EPB41L3, EPHB6, ERBB3, FBLN2, FBN2, FOXL2, GNAS, GSTP1, HS3ST2, HPN, IGFBP7, IRF7, JAM3, LOX, LY6D, LY6K, MACF1, MCAM, NCBP1, NEFH, NID2, PCDHB15, PCDHGA12, PFKP, PGRMC1, PHACTR3, PHKA2, POMC, PRKCA, PSEN1, RASSF1A, RASSF2, RBP1, RRAD, SFRP1, SGK, SOD3, SOX17, SULF2, TIMP3, TJP2, TRPV2, UCHL1, WDR69, ZFP42, ZNF442, and ZNF655.
Other inventorsSee patent
Recommendations received
2 people have recommended Wim
Join now to viewMore activity by Wim
-
🚀 Mission accomplished! Two weeks ago, our BioLizard scientists participated in our innovation hackathon to develop solutions to address critical…
🚀 Mission accomplished! Two weeks ago, our BioLizard scientists participated in our innovation hackathon to develop solutions to address critical…
Liked by Wim Van Criekinge
-
📣 Big announcement We’re delighted to announce the acquisition of OHMX.bio, a Ghent University spin-off specialized in advanced -omics technology…
📣 Big announcement We’re delighted to announce the acquisition of OHMX.bio, a Ghent University spin-off specialized in advanced -omics technology…
Liked by Wim Van Criekinge
-
We welcome OHMX.bio as part of the anacura family today! 🎉 Established in 2019 as a Ghent University spin-off, OHMX.bio specializes in advanced…
We welcome OHMX.bio as part of the anacura family today! 🎉 Established in 2019 as a Ghent University spin-off, OHMX.bio specializes in advanced…
Liked by Wim Van Criekinge
-
We are delighted to announce that OHMX.bio is now part of the anacura family! 🙌 As a Ghent University spin-off, OHMX.bio has always been at the…
We are delighted to announce that OHMX.bio is now part of the anacura family! 🙌 As a Ghent University spin-off, OHMX.bio has always been at the…
Liked by Wim Van Criekinge
-
Spannend! We duimen voor de finale plaats, maar dit nieuws is al indrukwekkend. Zo fier dat we deze spin-of hebben mogen ondersteunen via…
Spannend! We duimen voor de finale plaats, maar dit nieuws is al indrukwekkend. Zo fier dat we deze spin-of hebben mogen ondersteunen via…
Liked by Wim Van Criekinge
-
We are currently celebrating the 20th anniversary of the first isolation of #graphene. It is striking that after the hype and the valley of…
We are currently celebrating the 20th anniversary of the first isolation of #graphene. It is striking that after the hype and the valley of…
Liked by Wim Van Criekinge
-
⚡🔋🌋🔥 Are you ready to supercharge your startup? Join our Startup Campus! The perfect place and network to build your rocket ship. Apply now!…
⚡🔋🌋🔥 Are you ready to supercharge your startup? Join our Startup Campus! The perfect place and network to build your rocket ship. Apply now!…
Liked by Wim Van Criekinge
-
Cresco is proud to announce that it has acted as lead counsel for the investment by Novalis Biotech, an early stage venture capital investor in life…
Cresco is proud to announce that it has acted as lead counsel for the investment by Novalis Biotech, an early stage venture capital investor in life…
Liked by Wim Van Criekinge
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More